|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Cushing's Syndrome | |||||
| 2 | Additional conditions recognized in this trial | ||||
| Cushing Syndrome | |||||
| Syndrome | |||||
| 3 | More general conditions related to this trial | ||||
| Adrenal Gland Diseases | |||||
| Adrenocortical Hyperfunction | |||||
| Disease | |||||
| Endocrine System Diseases | |||||
| Pathologic Processes | |||||
| 4 | Additional drug interventions recognized in this trial | ||||
| Corticotropin-Releasing Hormone | |||||
| 5 | More general drug interventions related to this trial | ||||
| Hormones | |||||
| Hormones, Hormone Substitutes, and Hormone Antagonists | |||||
| Pharmacologic Actions | |||||
| Physiological Effects of Drugs | |||||
| 6 | Sponsors listed in this trial | ||||
| Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | |||||